Evidence map›Paper›PMID 30649651›Full record

ArticleWiener medizinische Wochenschrift (1946)2019

Clinical melanoma characteristics and survival-a single-center retrospective study between 2000 and 2010.

Valentin Feichtenschlager, Felix Weihsengruber, Leo Richter, Igor Vujic, Klemens Rappersberger, Christian Posch

Abstract read
PubMed Publisher
In one paragraph

Article in Wiener medizinische Wochenschrift (1946), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Valentin FeichtenschlagerDepartment of Dermatology and Venereology, Rudolfstiftung Hospital, Juchgasse 25, 1030, Vienna, Austria. valentin.feichtenschlager@hotmail.com.ORCID http://orcid.org/0000-0002-8465-6239
Felix WeihsengruberDepartment of Dermatology and Venereology, Rudolfstiftung Hospital, Juchgasse 25, 1030, Vienna, Austria.
Leo RichterDepartment of Dermatology and Venereology, Rudolfstiftung Hospital, Juchgasse 25, 1030, Vienna, Austria.
Igor VujicDepartment of Dermatology and Venereology, Rudolfstiftung Hospital, Juchgasse 25, 1030, Vienna, Austria.
Klemens RappersbergerDepartment of Dermatology and Venereology, Rudolfstiftung Hospital, Juchgasse 25, 1030, Vienna, Austria.
Christian PoschDepartment of Dermatology and Venereology, Rudolfstiftung Hospital, Juchgasse 25, 1030, Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to characterize clinical, histological, and outcome features of primary melanoma in 1329 patients managed at a single-center institution between 2000 and 2010. Parameters included age at diagnosis, sex, tumor location, histology, stage, Breslow thickness, and sentinel lymph node status among others. The mean age at diagnosis was 59.1 ± 16.7 years. Women were significantly younger than men when diagnosed (57.2 vs. 61.0 years; p < 0.001). Most melanomas (83%) were diagnosed on typically sun-exposed skin areas. Superficial spreading melanoma (39.5%) was the most frequent histological subtype. The median Breslow thickness was significantly higher for men compared to women (1.10 mm vs. 0.90 mm; p = 0.018). 38.3% of patients with positive and 12.9% of patients with negative sentinel biopsies progressed. Five-year survival analysis for a sub-cohort of 577 patients showed better 5‑year overall survival for woman compared to men (75.8% vs. 63.6%; p = 0.025). Our findings indicate differences in patient characteristics between men and women, and underscore the importance of early melanoma detection to prevent disease progression.

Indexed as

MelanomaSkin NeoplasmsAdultAgedFemaleHumansLymphatic MetastasisMaleMiddle AgedPrognosisRetrospective StudiesAustriaDiagnosisMelanomaSex distributionSurvival

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.